BioCryst Pharmaceutical Inc. (BCRX)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

4505 EMPEROR BOULEVARD DURHAM, NC 27703

BioCryst Pharmaceutical Inc. operates as a biopharmaceutical company which uses structure-based drug design to discover and design novel, small-molecule pharmaceutical products for the treatment of cancer, cardiovascular and autoimmune diseases and viral infections.

Data as of 2021-05-01 10:09:50 -0400
Market Cap2.067 Billion Shares Outstanding177.648 Million Avg 30-day Volume3.173 Million
P/E Ratio-11.30622 Dividend Yield0.0 EPS-1.09
Price/Sales116.29 Debt to Equity-17.38 EBITDA-174.009 Million
Price to Book Value-107.54 Forward PE-11.35 Enterprise Value2.045 Billion
Total Cash300.366 Million Current Debt105.654 Million Gross Profit16.262 Million
BETA1.29798 52-week High/Low14.24 / 3.3 Next Earnings Date2021-05-06 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from BCRX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 2 50.0% 3 (0.18%) 2 (0.12%) 50.0%
Funds Holding: 174 151 15.23% 54 (3.24%) 46 (2.86%) 17.39%
13F shares: 120.529 Million 126.553 Million -4.76% 61.822 Million 60.406 Million 2.34%
% Ownership 68.2632 71.6747 -4.76% 35.0138 34.2117 2.34%
New Positions: 38 25 52.0% 14 5 180.0%
Increased Positions 58 60 -3.33% 17 15 13.33%
Closed Positions 15 33 -54.55% 6 17 -64.71%
Reduced Positions 55 43 27.91% 18 19 -5.26%
Total Calls 1.561 Million 1.293 Million 20.68% 172 Thousand 313.4 Thousand -45.12%
Total Puts 1.483 Million 1.293 Million 14.66% 409.2 Thousand 382.9 Thousand 6.87%
PUT/CALL Ratio 0.95 1.0 -5.0% 2.38 1.22 95.08%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BCRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BCRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

4.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

THACKRAY HELEN M. CHIEF R&D OFFICER

  • Officer
  • Director
500,000 2021-03-31 2

JONES MICHAEL L EXEC. DIRECTOR, FINANCE - PAO

  • Officer
5,348 2021-03-18 3

HUTSON NANCY J

  • Director
64,756 2021-02-26 5

INGRAM ROBERT ALEXANDER

  • Director
75,013 2021-02-26 5

HEGGIE THERESA

  • Director
13,849 2021-02-26 5

ASELAGE STEVE

  • Director
31,496 2021-02-26 5

SHERIDAN WILLIAM P SENIOR VP - CMO

  • Officer
11,475 2021-02-22 3

BABU YARLAGADDA S SENIOR VP - DRUG DISCOVERY

  • Officer
183,156 2021-02-19 3

STONEHOUSE JON P PRESIDENT & CEO

  • Officer
  • Director
784,086 2020-12-15 3

BARNES ALANE P SENIOR VP, CHIEF LEGAL OFFICER

  • Officer
0 2020-12-15 4

SNIECINSKI MEGAN CHIEF BUSINESS OFFICER

  • Officer
0 2020-12-15 1

GAYER CHARLES K VICE PRESIDENT AND CCO

  • Officer
0 2020-12-15 1

DOYLE ANTHONY CHIEF FINANCIAL OFFICER

  • Officer
0 2020-12-15 2

ABERCROMBIE GEORGE B

  • Director
0 2020-05-12 1

LEE KENNETH B JR

  • Director
0 2020-05-12 1

LEVIN ALAN G

  • Director
0 2020-05-12 1

STAAB THOMAS R II SENIOR VICE PRESIDENT AND CFO

  • Officer
0 2020-02-21 0

POWELL LYNNE SENIOR VP - CCO

  • Officer
0 2019-01-25 0

ERCK STANLEY C

  • Director
48,333 2018-11-28 0

COHEN FRED E

  • Director
0 2018-06-20 0

PATEL SANJ K

  • Director
0 2017-05-24 0

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS (GP) LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
11,016,695 2016-08-12 0

SANDERS CHARLES A

  • Director
12,971 2016-02-29 0

JENSEN PEDER

  • Director
0 2014-05-02 0

BAKER FELIX

BAKER BROS. INVESTMENTS II, L.P.

BAKER/TISCH INVESTMENTS, LP

667, L.P.

BAKER BROTHERS LIFE SCIENCES LP

14159, L.P.

BAKER BROS. ADVISORS LP

BAKER JULIAN

BAKER BROS. ADVISORS (GP) LLC

BAKER BROS. INVESTMENTS, L.P.

  • 10% Owner
6,699,979 2013-08-01 0

BAKER BROS. ADVISORS (GP) LLC

  • 10% Owner
0 2013-07-01 0

HOROVITZ ZOLA P

  • Director
0 2012-05-23 0

HIGGINS JOHN L

  • Director
0 2012-05-23 0

BAKER BROS ADVISORS LLC

  • 10% Owner
0 2012-04-12 0

MCCULLOUGH DAVID VP

  • Officer
24,124 2012-03-15 0

LOWREY ROBERT S CONTROLLER, PAO

  • Officer
9,766 2012-03-15 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
3,841,124 2011-06-30 0

BAKER BROS. CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
62,407 2011-06-30 0

BIGGAR STEPHEN R

  • Director
0 2011-05-12 0

GRANT STUART SR VP & CFO

  • Officer
57,102 2011-03-16 0

SEIDENBERG BETH C

  • Director
0 2010-05-13 0

FEATHERINGILL WILLIAM W

  • Director
  • 10% Owner
0 2010-05-13 0

MILLS MIKE PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2010-03-12 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
17,241 2009-05-28 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
120,828 2009-05-28 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
1,522,015 2009-05-28 0

DARWIN MICHAEL A PRINCIPAL ACCOUNTING OFFICER

  • Officer
3,048 2008-07-31 0

STEER RANDOLPH C

  • Director
0 2008-05-21 0

BENNETT J CLAUDE CHIEF OPERATING OFFICER

  • Officer
  • Director
0 2008-03-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

THACKRAY HELEN M. - Director - Officer CHIEF R&D OFFICER

2021-04-02 17:26:34 -0400 2021-03-31 A 100,000 a 100,000 direct 0.4965 -5.6604 3.3764 3 -5.6604 6

THACKRAY HELEN M. - Director - Officer CHIEF R&D OFFICER

2021-04-02 17:26:34 -0400 2021-03-31 A 400,000 a 400,000 direct

JONES MICHAEL L - Officer EXEC. DIRECTOR, FINANCE - PAO

2021-03-22 16:19:34 -0400 2021-03-18 M 4,500 $3.51 a 5,348 direct -2.994 -7.9687 -1.6122 14.0949 24 -12.4827 14

JONES MICHAEL L - Officer EXEC. DIRECTOR, FINANCE - PAO

2021-03-22 16:19:34 -0400 2021-03-18 M 4,500 d 0 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 22:15:03 UTC -0.2334 0.2834 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 21:45:04 UTC -0.2334 0.2834 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 21:15:03 UTC -0.2334 0.2834 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 20:45:03 UTC -0.2111 0.2611 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 20:15:03 UTC -0.2111 0.2611 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 19:45:03 UTC -0.2111 0.2611 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 19:15:02 UTC -0.2111 0.2611 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 18:45:04 UTC -0.2111 0.2611 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 18:15:03 UTC -0.2111 0.2611 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 17:45:03 UTC -0.2111 0.2611 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 17:15:03 UTC -0.2111 0.2611 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 16:45:03 UTC -0.2111 0.2611 650000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 16:15:03 UTC -0.2111 0.2611 700000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 15:45:03 UTC -0.2111 0.2611 700000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 15:15:03 UTC -0.2111 0.2611 700000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 14:45:03 UTC -0.2077 0.2577 700000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 14:15:02 UTC -0.2077 0.2577 700000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 13:45:04 UTC -0.2077 0.2577 700000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 13:15:03 UTC -0.2077 0.2577 700000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-05-06 12:45:03 UTC -0.2077 0.2577 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund BCRX -7317.0 shares, $-54511.65 2020-12-31 N-PORT

Elevate your investments